# Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

> **NCT02542202** · NA · TERMINATED · sponsor: **University of Chicago** · enrollment: 25 (actual)

## Conditions studied

- Metastatic Renal Cell Cancer
- Recurrent Renal Cell Carcinoma
- Stage IV Renal Cell Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT02542202
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05-01
- **Primary completion:** 2023-03-23
- **Final completion:** 2023-03-23
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** due to slow enrollment
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542202, "Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02542202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*